Summary
It is of interest to characterize the regulatory mechanisms which control the synthesis of nerve growth factor (NGF) in order to design pharmacological procedures that might modulate the production of neurotrophic factor in vivo. This approach may be of valuable help in minimizing the deleterious effects of neurodegenerative diseases such as Alzheimer’s disease, which may affect NGF-responsive neurons.
Experiments performed with a line of mouse fibroblast-like cells demonstrated that serum increases the level of expression of NGF gene. The effect of serum on the NGF mRNA pool may be prevented by inhibitors of protein kinase activities, such as compound K 252a. This suggests that a protein phosphorylation step is involved in the up-regulation of NGF synthesis. The effect of serum can be mimicked both in fibroblasts and primary cultures of glial cells by the protein kinase C activator 12-O-tetradecanoyl-phorbol-13-acetate (TPA). This mechanism may be altered in neuropathological disorders such as Alzheimer’s disease or diabetes-associated peripheral neuropathy, where impaired or decreased protein kinase C activity is thought to take place.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rhamsdorf HJ, Jonat C, Herrlich P, Karin M (1987) Phorbolester-inducible genes contain a common cis-element recognized by a TPA-modulated trans-acting factor. Cell 49: 729–739
Angeletti RH, Bradshaw RA (1971) Nerve growth factor from mouse submaxillary gland: amino acid sequence. Proc Natl Acad Sci USA 68: 2417–2420
Brachet P, Dicou E (1984) L cells potentiate the effect of the extracellular NGF activity in co-cultures with PC 12 phechromocytoma cells. Exp Cell Res 150: 234–241
Castagna M, Takai Y, Kaibuchi S, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor promoting phorbol esters. J Biol Chem 257: 7847–7851
Chakrabarti S, Sima AAF, Lee J, Brachet P, Dicou E (1990) Nerve growth factor (NGF), proNGF and NGF receptor-like immunoreactivity in BB-rat retina. Brain Res 523: 11–15
Cohen S (1960) Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc Natl Acad Sci USA 46: 302–311
Cole G, Dobkins KR, Hansen LA, Terry RD, Saitoh T (1988) Decreased levels of protein kinase C in Alzheimer brain. Brain Res 452: 165–174
Coyle JT, Price DL, Delong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219: 1184–1190
Ehendal T, Larhammar D, Persson H (1986) Structure and expression of the chicken nerve growth factor gene. EMBO J 5: 1483–1487
Furukawa S, Furukawa Y, Satoyoshi E, Hayashi K (1987) Synthesis/secretion of nerve growth factor is associated with cell growth in cultured mouse astroglial cells. Biochem Biophys Res Commun 142: 395–402
Gnahn H, Hefti F, Heumann R, Schwab ME, Thoenen H (1983) NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Dev Brain Res 9: 45–52
Goedert M, Fine A, Hunt SP, Ullrich A (1986) Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer’s disease. Mol Brain Res 1: 85–92
Goedert M, Fine A, Dawbarn D, Wilcock GK, Chao MV (1989) Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer’s disease. Mol Brain Res 5: 1–7
Greene DA, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositides and sodium-potassium ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599–606
Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6: 2155–2162
Ileumann R, Korsching S, Bandtlow C, Thoenen H (1987) Changes of nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transections. J Cell Biol 104: 1623–1631
Hidaka H, Inagaki M, Kawamoto S, Sasaki Y (1984) Isoquinolinesulfonamide, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036–5041
Houlgatte R, Wion D, Barrand P, Dicou E, Brachet P (1986) Serum influences (3 NGF gene expression in mouse L cells. In: Levi-Montalcini R et al. (eds) Molecular aspects of neurobiology. Springer, Berlin Heidelberg New York, pp 40–42
Houlgatte R, Wion D, Brachet P (1988) Serum contains a macromolecular effector promoting the synthesis of nerve growth factor (NGF) in L cells. Biochem Biophys Res Commun 150: 723–730
Houlgatte R, Wion D, Brachet P (1989a) Levels of nerve growth factor secreted by rat primary fibroblasts and iris transplants are influenced by serum and glucocorticoids. Dev Brain Res 47: 171–179
Houlgatte R, Mallat M, Brachet P, Prochiantz A (1989b) Secretion of nerve growth factor in cultures of glial cells and neurons derived from different regions of the mouse brain. J Neurosci Res 24: 143–152
Huynh TV, Cole G, Katzman R, Huang KP, Saitoh T (1989) Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer’s disease fibroblasts. Arch Neurol 46: 1195–1199
Jung-Testas I, Beaulieu EE (1979) Effects of sex steroids and anti-hormones on growth, adhesiveness and receptors of L-929 cells cultured in serum-containing and serum-free media. Exp Cell Res 119: 75–85
Kase H, Iwahashi K, Matsuda Y (1986) K-252 a, a potent inhibitor of protein kinase C from microbial origin. J Antibiotics 39: 1059–1065
Korsching S, Thoenen H (1983) Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation. Proc Natl Acad Sci USA 80: 3513–3516
Korsching S, Auburger C, Heumann R, Scott J, Thoenen H (1985) Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 4: 1389–1393
Levi-Montalcini R, Hamburger V (1951) Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 116: 321–362
Meir R, Becker-André M, Götz R, Heumann R, Shaw A, Thoenen H (1986) Molecular cloning of bovine and chick nerve growth factor (NGF): delineation of conserved and unconserved domains and their relationship to the biological activity and antigenicity of NGF. EMBO J 5: 1489–1493
Mobley WC, Rutkowski JL, Tennekoon GI, Buchanan K, Johnston MV (1985) Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science 229: 284–287
Mobley WC, Rutkowski JL, Tennekoon GI, Gemski J, Buchanan K, Johnston MV (1986) Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Mol Brain Res 1: 53–62
Oger J, Arnason BGW, Pantazis N, Lehrich J, Young M (1974) Synthesis of nerve growth factor by L and 3T3 cells in culture. Proc Natl Acad Sci USA 71: 1554–1558
Rich KM, Luszynski JB, Osborne PA, Yip HK, Johnson EM (1987) Nerve growth factor protects adult sensory neurons from cell death and atrophy caused by axotomy. J Neurocytol 16: 261–267
Sassone-Corsi P, Lamph WW, Kamps M, Verma IM (1988) Fos-associated cellular p39 is related to nuclear transcription factor AP1. Cell 54: 553–560
Scott J, Selby M, Urdea M, Quiroga M, Bell GI, Rutter WJ (1983) Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature 302: 538–540
Schüle R, Umesono K, Mangelsdorf DJ, Bolado J, Wesley Pike J, Evans RM (1990) Jun-Fos and receptors for vitamin A and D recognize a common response element in the human osteocalcin gene. Cell 61: 497–504
Selby MJ, Edwards R, Sharp F, Rutter WJ (1987) Mouse nerve growth factor gene: structure and expression. Mol Cell Biol 7: 3057–3064
Senut MC, Lamour Y, Lee J, Brachet P, Dicou E (1990) Neuronal localization of the nerve growth factor precursor-like immunoreactivity in the rat brain. Int J Dev Neurosci 8: 65–80
Shelton DL, Reichardt LF (1986) Studies on the expression of the 13 nerve growth factor (NGF) gene in the central nervous system: level and regional distributions of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc Natl Acad Sci USA 83: 2714–2718
Thomas PK, Eliasson SG (1975) Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH (eds) Peripheral neuropathy. Saunders, Philadelphia, pp 956–981
Ullrich A, Gray A, Berman C, Dull TJ (1983) Human (3-nerve growth factor gene sequence highly homologous to that of mouse. Nature 303: 821–825
Westermann R, Hardung M, Meyer DK, Ehrhard P, Otten U, Unsicker K (1988) Neuronotrophic factors released by C6 glioma cells. J Neurochem 50: 1747–1758
Whittemore SR, Friedman PL, Larhammar D, Persson H, Gonzalez-Carvajal M, Holets VR (1988) Rat (3-nerve growth factor sequence and site of synthesis in the adult hippocampus. J Neurosci Res 20: 403–410
Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transections. Proc Natl Acad Sci USA 83: 9231–9235
Wion D, Barrand P, Dicou E, Scott J, Brachet P (1985) Serum and thyroid hormones T3 and T4 regulate nerve growth factor mRNA levels in mouse L cells. FEBS Lett 189: 37–41
Wion D, Houlgatte R, Brachet P (1986a) Dexamethasone rapidly reduces the expression of the 13NGF gene in mouse L-929 cells. Exp Cell Res 162: 562–565
Wion D, Perret C, Fréchin N, Keller A, Béhar G, Brachet P, Auffray C (1986b) Molecular cloning of the avian 3-nerve growth factor gene: transcription in brain. FEBS Lett 203: 82–86
Wion D, Houlgatte R, Barbot N, Barrand P, Dicou E, Brachet P (1987) Retinoic acid increases the expression of NGF gene in mouse L cells. Biochem Biophys Res Comm 149: 510–514
Wion D, MacGrogan D, Houlgatte R, Brachet P (1990) Phorbol 12-myristate 13-acetate (PMA) increases the expression of the nerve growth factor (NGF) gene in mouse L-929 fibroblasts. FEBS Lett 262: 42–44
Zheng M, Heinrich G (1988) Structural and functional analysis of the promoter region of the nerve growth factor gene. Mol Brain Res 3: 133–140
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Brachet, P., Houlgatte, R., Neveu, I., MacGrogan, D., Wion, D. (1991). Involvement of Protein Kinase C in the Regulation of Nerve Growth Factor Synthesis: A Possible Cause of Impaired Trophic Supply in Alzheimer’s Disease?. In: Hefti, F., Brachet, P., Will, B., Christen, Y. (eds) Growth Factors and Alzheimer’s Disease. Research and Perspectives in Alzheimer’s Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46722-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-46722-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46724-0
Online ISBN: 978-3-642-46722-6
eBook Packages: Springer Book Archive